Its overexpression in turn has been shown to prevent mortality and modulate macrophage polarization in IAV infection in mice (38) and inhaled GM-CSF therapy has been shown to have benefits in patients with pneumonia-associated acute respiratory distress syndrome (39). The gene discussed is CSF2; the disease is pneumonia.